Evidence map›Paper›PMID 29075112›Full record

ArticleInternational journal of nanomedicine2017

Effect of inhibitors of endocytosis and NF-kB signal pathway on folate-conjugated nanoparticle endocytosis by rat Kupffer cells.

Hongbo Tang, Hongli Chen, Yajing Jia, Xiaoyan Liu, Zhaohong Han, Aihua Wang, Qi Liu, Xinlei Li, Xin Feng

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Nanomaterial-induced mitochondrial biogenesis enhances intercellular mitochondrial transfer efficiency.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hongbo TangDepartment of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing.
Hongli ChenSchool of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Yajing JiaSchool of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Xiaoyan LiuDepartment of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing.
Zhaohong HanDepartment of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing.
Aihua WangDepartment of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing.
Qi LiuDepartment of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing.
Xinlei LiDepartment of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing.
Xin FengDepartment of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing.
Beijing Obstetrics and Gynecology Hospital · CNXinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regular accumulation of nanoparticles in the liver makes them hepatotoxic and decreases the circulation time, thus reducing their therapeutic effect. Resolving this problem will be significant in improving bioavailability and reducing side effects. In this study, we reduced the phagocytosis of epirubicin (EPI)-loaded folic acid-conjugated pullulan acetate (FPA/EPI) nanoparticles by Kupffer cells (KCs) through internalization and nuclear factor kappa B (NF-kB) signal pathway inhibitors, thus allowing development of FPA/EPI nanoparticles as a nanodrug delivery system (NDDS) based on our previous study. FPA/EPI nanoparticles were prepared by the dialysis method. Rat KCs were preincubated with the following individual or compound inhibitors: chlorpromazine (CPZ), nystatin (NY), colchicine (Col), amiloride (AMR), and pyrrolidine dithiocarbamate (PDTC). Dose- and time-dependent cellular uptake effects of inhibitors on FPA/EPI nanoparticles were determined through fluorometry. The cytokine levels of tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and IL-6 were tested in culture supernatants by bead-based multiplex flow cytometry. The uptake study demonstrated that inhibitors had an obvious inhibitory effect (

Indexed as

AmilorideAnimalsChlorpromazineClathrinColchicineCytokinesEndocytosisEpirubicinFolic AcidGlucansI-kappa B ProteinsKupffer CellsMacrophagesNanoparticlesNF-kappa BNystatinAmilorideChlorpromazineClathrinColchicineCytokinesEpirubicinFolic AcidGlucansI-kappa B ProteinsNF-kappa BNystatinpullulanpyrrolidine dithiocarbamic acidPyrrolidinesThiocarbamatesTumor Necrosis Factor-alphaendocytosis inhibitorfolate-conjugated pullulan acetateKupffer cellsnanodrug delivery systemNF-kB signal pathway

Identifiers

PMID29075112
PMCPMC5609780
OpenAlexW2754443541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.